Blocking Circ-CNST Suppresses Malignant Behaviors of Osteosarcoma Cells and Inhibits Glycolysis Through Circ-CNST-miR-578-LDHA/PDK1 CeRNA Networks

Overview

Journal J Orthop Surg Res

Publisher Biomed Central

Specialty Orthopedics

Date 2021 May 8

PMID 33962616

Citations 14

Authors

Rui Hu

Shan Chen

Jianxin Yan

Affiliations

Soon will be listed here.

Abstract

Background: CircRNA CNST (circ-CNST) is a newly identified biomarker for prognosis of osteosarcoma (OS). However, its role in OS progression remains to be well documented.

Methods: Expression of circ-CNST, microRNA (miR)-578, lactate dehydrogenase A (LDHA), and pyruvate dehydrogenase kinase 1 (PDK1) was detected by quantitative real-time polymerase chain reaction and Western blotting. The physical interaction was confirmed by dual-luciferase reporter assay. Cell behaviors and glycolysis were measured by 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide assay, colony formation assay, flow cytometry, transwell assays, xenograft experiment, and commercial kits.

Results: Circ-CNST was upregulated in human OS tissues and cells, accompanied with downregulation of miR-578 and upregulation of LDHA and PDK1. There were negative correlations between miR-578 expression and circ-CNST or LDHA/PDK1 in OS tissues. Moreover, high circ-CNST/LDHA/PDK1 or low miR-578 might predict shorter overall survival, advanced TNM stages, and lymph node metastasis. Physically, miR-578 was targeted by circ-CNST, and miR-578 could target LDHA/PDK1. Functionally, blocking circ-CNST and restoring miR-578 enhanced apoptosis rate and suppressed cell proliferation, colony formation, migration, and invasion in 143B and U2OS cells, accompanied with decreased glucose consumption, lactate production, and adenosine triphosphate (ATP)/adenosine diphosphate (ADP) ratio. Furthermore, in vivo growth of U2OS cells was retarded by silencing circ-CNST. Depletion of miR-578 could counteract the suppressive role of circ-CNST deficiency in 143B and U2OS cells, and restoring LDHA or PDK1 partially reversed the role of miR-578 inhibition as well.

Conclusion: Circ-CNST knockdown could antagonize malignant behaviors and glycolysis of OS cells by regulating miR-578-LDHA/PDK1 axes.

Citing Articles

Exploring the Role of Circular RNA in Bone Biology: A Comprehensive Review.

Valenti M, Zerlotin R, Cominacini M, Bolognin S, Grano M, Dalle Carbonare L Cells. 2024; 13(12.

PMID: 38920630 PMC: 11201515. DOI: 10.3390/cells13120999.

Osteosarcoma in a ceRNET perspective.

Mosca N, Alessio N, Di Paola A, Marrapodi M, Galderisi U, Russo A J Biomed Sci. 2024; 31(1):59.

PMID: 38835012 PMC: 11151680. DOI: 10.1186/s12929-024-01049-y.

Alteration in the Expression of Circular Rnas and its association with the Development and Progression of Osteosarcoma, an Integrative Review with High Sensitivity Research.

Lima F, Fernandes F, Almeida D, Carvalho A, Almeida V, Cavalcante G Asian Pac J Cancer Prev. 2024; 25(4):1195-1203.

PMID: 38679978 PMC: 11162731. DOI: 10.31557/APJCP.2024.25.4.1195.

CircGPC3 promotes hepatocellular carcinoma progression and metastasis by sponging miR-578 and regulating RAB7A/PSME3 expression.

Ju L, Luo Y, Cui X, Zhang H, Chen L, Yao M Sci Rep. 2024; 14(1):7632.

PMID: 38561366 PMC: 10984923. DOI: 10.1038/s41598-024-58004-y.

Identification of circRNA biomarkers in osteosarcoma: An updated systematic review and meta-analysis.

Zhou C, Balmer L, Song M, Mahara G, Wu K, Wang W Noncoding RNA Res. 2024; 9(2):341-349.

PMID: 38505307 PMC: 10945140. DOI: 10.1016/j.ncrna.2024.01.007.

References

Wang C, Jing J, Cheng L . Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma. Invest New Drugs. 2018; 36(6):1116-1132. DOI: 10.1007/s10637-018-0624-7. View

Ji X, Shan L, Shen P, He M . Circular RNA circ_001621 promotes osteosarcoma cells proliferation and migration by sponging miR-578 and regulating VEGF expression. Cell Death Dis. 2020; 11(1):18. PMC: 6944700. DOI: 10.1038/s41419-019-2204-y. View

Giang A, Raymond T, Brookes P, Bentley K, Schwarz E, OKeefe R . Mitochondrial dysfunction and permeability transition in osteosarcoma cells showing the Warburg effect. J Biol Chem. 2013; 288(46):33303-11. PMC: 3829176. DOI: 10.1074/jbc.M113.507129. View

Wan B, Hu H, Wang R, Liu W, Chen D . Therapeutic Potential of Circular RNAs in Osteosarcoma. Front Oncol. 2020; 10:370. PMC: 7174900. DOI: 10.3389/fonc.2020.00370. View

Gao S, Tu D, Li H, Jiang J, Cao X, You J . Pharmacological or genetic inhibition of LDHA reverses tumor progression of pediatric osteosarcoma. Biomed Pharmacother. 2016; 81:388-393. DOI: 10.1016/j.biopha.2016.04.029. View

Li S, Zeng M, Yang L, Tan J, Yang J, Guan H . Hsa_circ_0008934 promotes the proliferation and migration of osteosarcoma cells by targeting miR-145-5p to enhance E2F3 expression. Int J Biochem Cell Biol. 2020; 127:105826. DOI: 10.1016/j.biocel.2020.105826. View

Fang A, Zhang Q, Fan H, Zhou Y, Yao Y, Zhang Y . Discovery of human lactate dehydrogenase A (LDHA) inhibitors as anticancer agents to inhibit the proliferation of MG-63 osteosarcoma cells. Medchemcomm. 2018; 8(8):1720-1726. PMC: 6072013. DOI: 10.1039/c7md00222j. View

Soghli N, Qujeq D, Yousefi T, Soghli N . The regulatory functions of circular RNAs in osteosarcoma. Genomics. 2020; 112(4):2845-2856. DOI: 10.1016/j.ygeno.2020.03.024. View

Wang D, Yang S, Wang H, Wang J, Zhang Q, Zhou S . The progress of circular RNAs in various tumors. Am J Transl Res. 2018; 10(6):1571-1582. PMC: 6038087. View

10.

Chen H, Gao S, Cheng C . MiR-323a-3p suppressed the glycolysis of osteosarcoma via targeting LDHA. Hum Cell. 2018; 31(4):300-309. DOI: 10.1007/s13577-018-0215-0. View

11.

Wu Y, Xie Z, Chen J, Chen J, Ni W, Ma Y . Circular RNA circTADA2A promotes osteosarcoma progression and metastasis by sponging miR-203a-3p and regulating CREB3 expression. Mol Cancer. 2019; 18(1):73. PMC: 6444890. DOI: 10.1186/s12943-019-1007-1. View

12.

Zhang Z, Pu F, Wang B, Wu Q, Liu J, Shao Z . Hsa_circ_0000285 functions as a competitive endogenous RNA to promote osteosarcoma progression by sponging hsa-miRNA-599. Gene Ther. 2019; 27(5):186-195. DOI: 10.1038/s41434-019-0112-5. View

13.

Cao W, Wang Z, Han X, Liu J, Wang W . In vitro cytotoxicity screening to identify novel anti-osteosarcoma therapeutics targeting pyruvate dehydrogenase kinase 2. Bioorg Med Chem Lett. 2019; 29(20):126665. DOI: 10.1016/j.bmcl.2019.126665. View

14.

Emmanouilidi A, Falasca M . Targeting PDK1 for Chemosensitization of Cancer Cells. Cancers (Basel). 2017; 9(10). PMC: 5664079. DOI: 10.3390/cancers9100140. View

15.

Pereira-Nunes A, Afonso J, Granja S, Baltazar F . Lactate and Lactate Transporters as Key Players in the Maintenance of the Warburg Effect. Adv Exp Med Biol. 2020; 1219:51-74. DOI: 10.1007/978-3-030-34025-4_3. View

16.

Chen Z, Wang F, Xiong Y, Wang N, Gu Y, Qiu X . CircZFR functions as a sponge of miR-578 to promote breast cancer progression by regulating HIF1A expression. Cancer Cell Int. 2020; 20:400. PMC: 7437024. DOI: 10.1186/s12935-020-01492-5. View

17.

Li Z, Shen J, Chan M, Wu W . MicroRNA-379 suppresses osteosarcoma progression by targeting PDK1. J Cell Mol Med. 2016; 21(2):315-323. PMC: 5264134. DOI: 10.1111/jcmm.12966. View

18.

Jin L, Chun J, Pan C, Alesi G, Li D, Magliocca K . Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis. Oncogene. 2017; 36(27):3797-3806. PMC: 5501759. DOI: 10.1038/onc.2017.6. View

19.

Han T, Kang D, Ji D, Wang X, Zhan W, Fu M . How does cancer cell metabolism affect tumor migration and invasion?. Cell Adh Migr. 2013; 7(5):395-403. PMC: 3903682. DOI: 10.4161/cam.26345. View

20.

Zheng X, Xu C, Wang F . MiR-33b inhibits osteosarcoma cell proliferation through suppression of glycolysis by targeting Lactate Dehydrogenase A (LDHA). Cell Mol Biol (Noisy-le-grand). 2018; 64(11):31-35. View